Concepts and controversies of juvenile myoclonic epilepsy: still an enigmatic epilepsy

References

• Janz D. Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy). Acta Neurol Scand 1985;72(5):449-59
   PubMedGoogle Scholar
• Herpin T. Des accès incomplets d’épilepsie. Baillière; Paris: 1867. p. 162-70
   Google Scholar
• Janz D, Christian W. Impulsiv - petit mal. translated into English by Genton P In: Malatosse A, Genton P, Hirsch E, editors. Idiopathic generalized epilepsies: clinical, experimental and genetic aspects. John Libbey; London, UK: 1994. p. 229-51
   Google Scholar
• Kasteleijn-Nolst Trenité DG, Schmitz B, Janz D, et al. Consensus on diagnosis and management of JME: from founder’s observations to current trends. Epilepsy Behav 2013;28(Suppl 1):S87-90
   PubMed Web of Science ®Google Scholar
• Aliberti V, Grunewald RA, Panayiotopoulos CP, Chroni E. Focal electroencephalographic abnormalities in juvenile myoclonic epilepsy. Epilepsia 1994;35(2):297-301
   PubMedGoogle Scholar
• Koepp MJ. Juvenile myoclonic epilepsy – A generalized epilepsy syndrome? Acta Neurol Scand 2005(Suppl 181):57-62
   Google Scholar
• Swartz BE, Simpkins F, Halgren E, et al. Visual working memory in primary generalized epilepsy: an 18FDG-PET study. Neurology 1996;47(5):1203-12
   PubMedGoogle Scholar
• Prevett MC, Duncan JS, Jones T, et al. Demonstration of thalamic activation during typical absence seizures using H2(15)O and PET. Neurology 1995;45(7):1396-402
   PubMedGoogle Scholar
• Bartenstein PA, Duncan JS, Prevett MC, et al. Investigation of the opioid system in absence seizures with positron emission tomography. J Neurol Neurosurg Psychiatry 1993;56(12):1295-302
   PubMedGoogle Scholar
• Meschaks A, Lindstrom P, Halldin C, et al. Regional reductions in serotonin 1A receptor binding in juvenile myoclonic epilepsy. Arch Neurol 2005;62(6):946-50
   PubMedGoogle Scholar
• Ciumas C, Wahlin TB, Jucaite A, et al. Reduced dopamine transporter binding in patients with juvenile myoclonic epilepsy. Neurology 2008;71(11):788-94
   PubMedGoogle Scholar
• Savic I, Lekvall A, Greitz D, Helms G. MR spectroscopy shows reduced frontal lobe concentrations of N-acetyl aspartate in patients with juvenile myoclonic epilepsy. Epilepsia 2000;41(3):290-6
   PubMedGoogle Scholar
• Mory SB, Li LM, Guerreiro CA, Cendes F. Thalamic dysfunction in juvenile myoclonic epilepsy: a proton MRS study. Epilepsia 2003;44(11):1402-5
   PubMedGoogle Scholar
• Lin K, Carrete H Jr, Lin J, et al. Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy. Epilepsia 2009;50(5):1191-200
   PubMedGoogle Scholar
• Savic I, Osterman Y, Helms G. MRS shows syndrome differentiated metabolite changes in human-generalized epilepsies. Neuroimage 2004;21(1):163-72
   PubMedGoogle Scholar
• Betting LE, Mory SB, Li LM, et al. Voxel-based morphometry in patients with idiopathic generalized epilepsies. Neuroimage 2006;32(2):498-502
   PubMedGoogle Scholar
• Pulsipher DT, Seidenberg M, Guidotti L, et al. Thalamofrontal circuitry and executive dysfunction in recent-onset juvenile myoclonic epilepsy. Epilepsia 2005;50(5):1210-19
   Google Scholar
• Woermann FG, Free SL, Koepp MJ, et al. Abnormal cerebral structure in juvenile myoclonic epilepsy demonstrated with voxel-based analysis of MRI. Brain 1999;122(11):2101-8
   PubMedGoogle Scholar
• Kim JH, Lee JK, Koh SB, et al. Regional grey matter abnormalities in juvenile myoclonic epilepsy: a voxel-based morphometry study. Neuroimage 2007;37(4):1132-7
   PubMedGoogle Scholar
• Tae WS, Kim SH, Joo EY, et al. Cortical thickness abnormality in juvenile myoclonic epilepsy. J Neurol 2008;255(4):561-6
   PubMedGoogle Scholar
• Alhusaini S, Ronan L, Scanlon C, et al. Regional increase of cerebral cortex thickness in juvenile myoclonic epilepsy. Epilepsia 2013;54(9):e138-41
   Google Scholar
• O’Muircheartaigh J, Vollmar C, Barker GJ, et al. Focal structural changes and cognitive dysfunction in juvenile myoclonic epilepsy. Neurology 2011;76(1):34-40
   PubMedGoogle Scholar
• Vulliemoz S, Vollmar C, Koepp MJ, et al. Connectivity of the supplementary motor area in juvenile myoclonic epilepsy and frontal lobe epilepsy. Epilepsia 2011;52(3):507-14
   PubMed Web of Science ®Google Scholar
• O’Muircheartaigh J, Vollmar C, Barker GJ, et al. Abnormal thalamocortical structural and functional connectivity in juvenile myoclonic epilepsy. Brain 2012;135(Pt 12):3635-44
   PubMedGoogle Scholar
• Vollmar C, O’Muircheartaigh J, Barker GJ, et al. Motor system hyperconnectivity in juvenile myoclonic epilepsy: a cognitive functional magnetic resonance imaging study. Brain 2011;134(6):1710-19
   PubMedGoogle Scholar
• Wandschneider B, Thompson PJ, Vollmar C, Koepp MJ. Frontal lobe function and structure in juvenile myoclonic epilepsy: a comprehensive review of neuropsychological and imaging data. Epilepsia 2012;53(12):2091-8
   PubMed Web of Science ®Google Scholar
• Wandschneider B, Centeno M, Vollmar C, et al. Motor co-activation in siblings of juvenile myoclonic epilepsy patients: an imaging endophenotype? Brain 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• Archer JS, Abbott DF, Waites AB, Jackson GD. fMRI “deactivation” of the posterior cingulate during generalized spike and wave. Neuroimage 2003;20(4):1915-22
   PubMedGoogle Scholar
• Aghakhani Y, Bagshaw AP, Benar CG, et al. fMRI activation during spike and wave discharges in idiopathic generalized epilepsy. Brain 2004;127(5):1127-44
   PubMedGoogle Scholar
• Gotman J, Grova C, Bagshaw A, et al. Generalized epileptic discharges show thalamocortical activation and suspension of the default state of the brain. Proc Natl Acad Sci USA 2005;102(42):15236-40
   PubMedGoogle Scholar
• Hamandi K, Salek-Haddadi A, Laufs H, et al. EEG-fMRI of idiopathic and secondarily generalized epilepsies. Neuroimage 2006;31(4):1700-10
   PubMed Web of Science ®Google Scholar
• Laufs H, Hamandi K, Salek-Haddadi A, et al. Temporal lobe interictal epileptic discharges affect cerebral activity in “default mode” brain regions. Hum Brain Mapp 2007;28(10):1023-32
   PubMed Web of Science ®Google Scholar
• Moeller F, LeVan P, Muhle H, et al. Absence seizures: individual patterns revealed by EEG-fMRI. Epilepsia 2010;51(10):2000-10
   PubMedGoogle Scholar
• Berg AT, Scheffer IE. New Concepts in classification of the epilepsies: Entering the 21st century. Epilepsia 2011;52:1058-62
   PubMedGoogle Scholar
• Sowell ER, Peterson BS, Thompson PM, et al. Mapping cortical change across the human life span. Nat Neurosci 2003;6:309-15
   PubMed Web of Science ®Google Scholar
• Thompson PM, Sowell ER, Gogtay N, et al. Structural MRI and brain development. Int Rev Neurobiol 2005;67:285-323
   PubMedGoogle Scholar
• Giorgio A, Watkins KE, Chadwick M, et al. Longitudinal changes in grey and white matter during adolescence. Neuroimage 2010;49(1):94-103
   PubMed Web of Science ®Google Scholar
• Schneider JF, Il’yasov KA, Hennig J, Martin E. Fast quantitative diffusion-tensor imaging of cerebral white matter from the neonatal period to adolescence. Neuroradiology 2004;46(4):258-66
   PubMed Web of Science ®Google Scholar
• Bourgeois JP, Rakic P. Changes of synaptic density in the primary visual cortex of the macaque monkey from fetal to adult stage. J Neurosci 1993;13(7):2801-20
   PubMed Web of Science ®Google Scholar
• Martınez-Juarez IE, Alonso EA, Medina MT, et al. Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up. Brain 2006;129:1269-80
   PubMed Web of Science ®Google Scholar
• Guaranha MS, Filho GM, Lin K, et al. Prognosis of juvenile myoclonic epilepsy is related to endophenotypes. Seizure 2011;20(1):42-8
   PubMedGoogle Scholar
• Geithner J, Schneider F, Wang Z, et al. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up. Epilepsia 2012;53(8):1379-86
   PubMed Web of Science ®Google Scholar
• Beck-Mannagetta G, Janz D. Syndrome-related genetics in generalized epilepsy. In: Anderson VE, Hauser WA, Leppik IE, Noebels JL, Rich SS, editors. Genetic strategies in epilepsy research. Epilepsy Research (suppl 4). Elsevier; Amsterdam, The Netherlands: 1991. p. 105-11
   Google Scholar
• Pal DK, Durner M, Klotz I, et al. Complex inheritance and parent-of-origin effect in juvenile myoclonic epilepsy. Brain Dev 2006;28(2):92-8
   PubMedGoogle Scholar
• Vadlamudi L, Andermann E, Lombroso CT, et al. Epilepsy in twins: insights from unique historical data of William Lennox. Neurology 2004;62(7):1127-33
   PubMedGoogle Scholar
• Winawer MR, Rabinowitz D, Pedley TA, et al. Genetic influences on myoclonic and absence seizures. Neurology 2003;61(11):1576-81
   PubMedGoogle Scholar
• Marini C, Scheffer IE, Crossland KM, et al. Genetic architecture of idiopathic generalized epilepsy: clinical genetic analysis of 55 multiplex families. Epilepsia 2004;45:467-78
   PubMed Web of Science ®Google Scholar
• Winawer MR, Marini C, Grinton BE, et al. Familial clustering of seizure types within the idiopathic generalized epilepsies. Neurology 2005;65:523-8
   PubMedGoogle Scholar
• Kinirons P, Rabinowitz D, Gravel M, et al. Phenotypic concordance in 70 families with IGE-implications for genetic studies of epilepsy. Epilepsy Res 2008;82(1):21-8
   PubMedGoogle Scholar
• Ottman R, Annegers JF, Hauser WA, Kurland LT. Higher risk of seizures in offspring of mothers than of fathers with epilepsy. Am J Hum Genet 1988;43:257-64
   PubMed Web of Science ®Google Scholar
• Greenberg DA, Delgado-Escueta AV, Widelitz H, et al. Juvenile myoclonic epilepsy may be linked to the Bf and HLA loci on human chromosome 6. Am J Med Genet 1988;31:185-92
   PubMedGoogle Scholar
• Cossette P, Liu L, Brisebois K, et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 2003;31(2):184-9
   Google Scholar
• Suzuki T, Delgado-Escueta AV, Aguan K, et al. Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat Genet 2004;36(8):842-9
   PubMedGoogle Scholar
• Suls A, Dedeken P, Goffin K, et al. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 2008;131(Pt 7):1831-44
   PubMedGoogle Scholar
• Mullen SA, Suls A, De Jonghe P, et al. Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology 2010;75(5):432-40
   PubMed Web of Science ®Google Scholar
• Ma S, Blair MA, Abou-Khalil B, et al. Mutations in the GABRA1 and EFHC1 genes are rare in familial juvenile myoclonic epilepsy. Epilepsy Res 2006;71(2-3):129-34
   PubMedGoogle Scholar
• Pinto D, Louwaars S, Westland B, et al. Heterogeneity at the JME 6p11-12 locus: absence of mutations in the EFHC1 gene in linked Dutch families. Epilepsia 2006;47(10):1743-6
   PubMedGoogle Scholar
• Annesi F, Gambardella A, Michelucci R, et al. Mutational analysis of EFHC1 gene in Italian families with juvenile myoclonic epilepsy. Epilepsia 2007;48(9):1686-90
   PubMed Web of Science ®Google Scholar
• Medina MT, Suzuki T, Alonso ME, et al. Novel mutations in Myoclonin1/EFHC1 in sporadic and familial juvenile myoclonic epilepsy. Neurology 2008;70(22 Pt 2):2137-44
   PubMedGoogle Scholar
• Jara-Prado A, Martínez-Juárez IE, Ochoa A, et al. Novel Myoclonin1/EFHC1 mutations in Mexican patients with juvenile myoclonic epilepsy. Seizure 2012;21(7):550-4
   PubMedGoogle Scholar
• Petrovski S, Wang Q, Heinzen EL, et al. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet 2013;9(8):e1003709
   PubMed Web of Science ®Google Scholar
• De Vivo DC, Trifiletti RR, Jacobson RI, et al. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 1991;325(10):703-9
   PubMed Web of Science ®Google Scholar
• Striano P, Weber YG, Toliat MR, et al. GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy. Neurology 2012;78(8):557-62
   PubMed Web of Science ®Google Scholar
• Kapoor A, Satishchandra P, Ratnapriya R, et al. An idiopathic epilepsy syndrome linked to 3q13.3-q21 and missense mutations in the extracellular calcium sensing receptor gene. Ann Neurol 2008;64(2):158-67
   PubMedGoogle Scholar
• Tan NC, Berkovic SF. The Epilepsy Genetic Association Database (epiGAD): analysis of 165 genetic association studies, 1996-2008. Epilepsia 2010;51(4):686-9
   PubMedGoogle Scholar
• Dibbens LM, Feng HJ, Richards MC, et al. GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies. Hum Mol Genet 2004;13(13):1315-19
   PubMed Web of Science ®Google Scholar
• Mas C, Taske N, Deutsch S, et al. Association of the connexion-36 gene with juvenile myoclonic epilepsy. J Med Genet 2004;41(7):e93
   Google Scholar
• Pal DK, Evgrafov OV, Tabares P, et al. BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy. Am J Hum Genet 2003;73(2):261-70
   PubMedGoogle Scholar
• Cavalleri GL, Walley NM, Soranzo N, et al. A multicenter study of BRD2 as a risk factor for juvenile myoclonic epilepsy. Epilepsia 2007;48(4):706-12
   PubMedGoogle Scholar
• Layouni S, Buresi C, Thomas P, et al. BRD2 and TAP-1 genes and juvenile myoclonic epilepsy. Neurol Sci 2010;31(1):53-6
   PubMed Web of Science ®Google Scholar
• Greenberg DA, Cayanis E, Strug L, et al. Malic enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsy. Am J Hum Genet 2005;76(1):139-46
   PubMedGoogle Scholar
• Lenzen KP, Heils A, Lorenz S, et al. Association analysis of malic enzyme 2 gene polymorphisms with idiopathic generalized epilepsy. Epilepsia 2005;46(10):1637-41
   PubMedGoogle Scholar
• Escayg A, De Waard M, Lee DD, et al. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet 2000;66(5):1531-9
   PubMedGoogle Scholar
• Mefford HC, Muhle H, Ostertag P, et al. Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet 2010;6(5):e1000962
   PubMed Web of Science ®Google Scholar
• de Kovel CG, Trucks H, Helbig I, et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 2010;133(Pt 1):23-32
   PubMedGoogle Scholar
• Steffens M, Leu C, Ruppert AK, et al. EPICURE Consortium; EMINet Consortium. Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. Hum Mol Genet 2012;21(24):5359-72
   PubMedGoogle Scholar
• Heinzen EL, Depondt C, Cavalleri GL, et al. Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. Am J Hum Genet 2012;91(2):293-302
   PubMedGoogle Scholar
• Camfield CS, Camfield PR. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology 2009;73(13):1041-5
   PubMedGoogle Scholar
• Syvertsen MR, Thuve S, Stordrange BS, Brodtkorb E. Clinical heterogeneity of juvenile myoclonic epilepsy: follow-up after an interval of more than 20 years. Seizure 2014;23:S1059-311
   Google Scholar
• Schneider-von Podewils F, Gasse C, Geithner J, et al. Clinical predictors of the long-term social outcome and quality of life in juvenile myoclonic epilepsy: 20-65 years of follow-up. Epilepsia 2014;55(2):322-30
   PubMedGoogle Scholar
• Moschetta S, Valente KD. Impulsivity and seizure frequency, but not cognitive deficits, impact social adjustment in patients with juvenile myoclonic epilepsy. Epilepsia 2013;54(5):866-70
   PubMedGoogle Scholar
• Gois J, Valente K, Vicentiis S, et al. Assessment of psychosocial adjustment in patients with temporal lobe epilepsy using a standard measure. Epilepsy Behav 2011;20(1):89-94
   PubMed Web of Science ®Google Scholar
• Zamarian L, Höfler J, Kuchukhidze G, et al. Decision making in juvenile myoclonic epilepsy. J Neurol 2013;260(3):839-46
   PubMedGoogle Scholar
• Wandschneider B, Centeno M, Vollmar C, et al. Risk-taking behavior in juvenile myoclonic epilepsy. Epilepsia 2013;54(12):2158-65
   PubMedGoogle Scholar
• Almane D, Jones JE, Jackson DC, et al. The social competence and behavioral problem substrate of new- and recent-onset childhood epilepsy. Epilepsy Behav 2014;31:91-6
   PubMed Web of Science ®Google Scholar
• de Araújo Filho GM, Yacubian EM. Juvenile myoclonic epilepsy: psychiatric comorbidity and impact on outcome. Epilepsy Behav 2013;28(Suppl 1):S74-80
   PubMedGoogle Scholar
• Filho GM, Mazetto L, da Silva JM, et al. Psychiatric comorbidity in patients with two prototypes of focal versus generalized epilepsy syndromes. Seizure 2011;20(5):383-6
   PubMedGoogle Scholar
• de Araújo Filho GM, Lin K, Lin J, et al. Are personality traits of juvenile myoclonic epilepsy related to frontal lobe dysfunctions? A proton MRS study. Epilepsia 2009;50(5):1201-9
   PubMedGoogle Scholar
• de Araújo Filho GM, de Araujo TB, Sato JR, et al. Personality traits in juvenile myoclonic epilepsy: evidence of cortical abnormalities from a surface morphometry study. Epilepsy Behav 2009;27(2):385-92
   Google Scholar
• de Araújo Filho GM, Jackowski AP, Lin K, et al. Personality traits related to juvenile myoclonic epilepsy: MRI reveals prefrontal abnormalities through a voxel-based morphometry study. Epilepsy Behav 2009;15(2):202-7
   PubMed Web of Science ®Google Scholar
• Janz D, Kern A, Mössinger HJ, Puhlmann U. Relapse prognosis following reduction of drugs in epilepsy treatment [in German]. Nervenarzt 1983;54:525-9
   PubMedGoogle Scholar
• Delgado-Escueta AV, Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology 1984;34:285-94
   PubMed Web of Science ®Google Scholar
• Penry JK, Dean JC, Riela AR. Juvenile myoclonic epilepsy: long-term response to therapy. Epilepsia 1989;30:S19-23
   PubMed Web of Science ®Google Scholar
• Schmidt D. Response to antiepilepileptic drugs and the rate of relapse after discontinuation in juvenile myoclonic epilepsy. In: Schmidt B, Sander T, editors. Juvenile Myoclonic Epilepsy: the Janz syndrome. Wrightson Biomedical Publishing Ltd; Petersfield, UK: 2006
   Google Scholar
• Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE Subcommission on AED Guidelines. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2013;54(3):551-63
   PubMed Web of Science ®Google Scholar
• Noachtar S, Andermann E, Meyvisch P, et al. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 2008;70:607-16
   PubMed Web of Science ®Google Scholar
• Morris GL, Hammer AE, Kustra RP, Messenheimer JA. Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study. Epilepsy Behav 2004;5:509-12
   PubMedGoogle Scholar
• Kothare SV, Valencia I, Khurana DS, et al. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Epileptic Disord 2004;6:267-70
   PubMed Web of Science ®Google Scholar
• Biton V, Bourgeois BF; YTC/YTCE Study Investigators. Topiramate in patients with juvenile myoclonic epilepsy. Arch Neurol 2005;62:1705-8
   PubMedGoogle Scholar
• Levisohn PM, Holland KD. Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison. Epilepsy Behav 2007;10:547-52
   PubMed Web of Science ®Google Scholar
• Guerrini R, Belmonte A, Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia 1998;39:S2-S10
   PubMed Web of Science ®Google Scholar
• Genton P. When antiepileptic drugs aggravate epilepsy. Brain Dev 2000;22:75-80
   PubMed Web of Science ®Google Scholar
• Fisher RS, Acevedo C, Arzimanoglou A, et al. An operational clinical definition of epilepsy. Epilepsia 2014;55(4):475-82
   PubMed Web of Science ®Google Scholar
• Martínez-Juárez IR, Alonso ME, Medina MT, et al. Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up. Brain 2006;129:1269-80
   PubMed Web of Science ®Google Scholar
• Baykan B, Altindag EA, Bebek N, et al. Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy. Neurology 2008;70:2123-9
   PubMed Web of Science ®Google Scholar
• Camfield CS, Camfield PR. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology 2009;73(13):1041-5
   PubMedGoogle Scholar
• Geithner J, Schneider F, Wang Z, et al. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up. Epilepsia 2012;53:1379-86
   PubMed Web of Science ®Google Scholar
• Senf P, Schmitz B, Holtkamp M, Janz D. Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors. Neurology 2013;81(24):2128-33
   PubMedGoogle Scholar
• Sillanpää M, Schmidt D. Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy. Brain 2009;132(4):989-98
   PubMedGoogle Scholar
• Medical Research Council Antiepileptic Drug Withdrawal Study Group. Randomized study of antiepileptic drug withdrawal in patients in remission. Lancet 1991;337:1175-80
   PubMedGoogle Scholar
• Chadwick D, Taylor J, Johnson T. Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it. The MRC Antiepileptic Drug Withdrawal Group. Epilepsia 1996;37(11):1043-50
   PubMedGoogle Scholar
• Siniatchkin M, Koepp MJ. Neuroimaging and neurogenetics of epilepsy in humans. Neuroscience 2009;164(1):164-73
   PubMedGoogle Scholar
• Monti B, Polazzi E, Contestabile A. Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol 2009;2(1):95-109
   PubMedGoogle Scholar
• Braun K, Schmidt D. Stopping antiepileptic drugs in seizure-free patients. Curr Opin Neurol 2014;27(2):219-26
   PubMed Web of Science ®Google Scholar
• Löscher W, Schmidt D. Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia 2011;52(4):657-78
   PubMed Web of Science ®Google Scholar
• Löscher W, Klitgaard H, Twyman RE, Schmidt D. New avenues for anti-epileptic drug discovery and development. Nat Rev Drug Discov 2013;12:757-76
   PubMed Web of Science ®Google Scholar
• Schmidt D. Is antiepileptogenesis a realistic goal in clinical trials? Concerns and new horizons. Epileptic Disord 2012;14:105-13
   PubMed Web of Science ®Google Scholar
• Engel J Jr, Thompson PM, Stern JM, et al. Connectomics and epilepsy. Curr Opin Neurol 2013;26:186-94
   PubMedGoogle Scholar
• Shinnar S, Berg AT, Moshé SL, et al. Discontinuing antiepileptic drugs in children with epilepsy: a prospective study. Ann Neurol 1994;35:534-45
   PubMed Web of Science ®Google Scholar
• Panayiotopoulos CP, Obeid T, Tahan AR. JME: a 5-year prospective study. Epilepsia 1994;35:285-96
   PubMed Web of Science ®Google Scholar